Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pLX311 Luciferase
(Plasmid #117735)

Ordering

Item Catalog # Description Quantity Price (USD)
Plasmid 117735 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.

Backbone

  • Vector backbone
    pLX311
  • Backbone manufacturer
    Broad Institute
  • Total vector size (bp) 9877
  • Vector type
    Mammalian Expression, Lentiviral
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    30°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    firefly Luciferase
  • Insert Size (bp)
    1649
  • Promoter EF1a
  • Tag / Fusion Protein
    • V5 (C terminal on backbone)

Cloning Information

Terms and Licenses

Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pLX311 Luciferase was a gift from William Hahn (Addgene plasmid # 117735 ; http://n2t.net/addgene:117735 ; RRID:Addgene_117735)
  • For your References section:

    MCL1 and DEDD promote urothelial carcinoma progression. Hong AL, Guerriero JL, Doshi MB, Kynnap BD, Kim WJ, Schinzel AC, Modiste R, Schlauch AJ, Adam RM, Kwiatkowski DJ, Beroukhim R, Letai A, Rosenberg JE, Hahn WC. Mol Cancer Res. 2019 Feb 18. pii: 1541-7786.MCR-18-0963. doi: 10.1158/1541-7786.MCR-18-0963. 10.1158/1541-7786.MCR-18-0963 PubMed 30777879